π
|
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
12 auth.
Christian T Ruff,
R. Giugliano,
E. Braunwald,
Elaine B Hoffman,
Naveen Deenadayalu,
M. Ezekowitz,
...
A. Camm,
Jeffrey I. Weitz,
Basil S. Lewis,
A. Parkhomenko,
T. Yamashita,
E. Antman
|
11 |
2014 |
11 π
|
π
|
Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination.
20 auth.
H. Inoue,
A. Fujiki,
H. Origasa,
S. Ogawa,
K. Okumura,
I. Kubota,
Y. Aizawa,
T. Yamashita,
H. Atarashi,
M. Horie,
...
T. Ohe,
Y. Doi,
A. Shimizu,
A. Chishaki,
T. Saikawa,
K. Yano,
A. Kitabatake,
H. Mitamura,
I. Kodama,
S. Kamakura
|
8 |
2009 |
8 π
|
π
|
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
16 auth.
S. Ogawa,
Y. Aizawa,
H. Atarashi,
H. Inoue,
S. Kamakura,
Y. Koretsune,
K. Kumagai,
H. Mitamura,
K. Okumura,
K. Sugi,
...
T. Yamashita,
M. Yasaka,
K. Hiejima,
I. Kodama,
T. Ohe,
K. Yano
|
7 |
2010 |
7 π
|
π¬
|
Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry.
H. Atarashi,
H. Inoue,
K. Okumura,
T. Yamashita,
N. Kumagai,
H. Origasa
|
7 |
2011 |
7 π¬
|
π
|
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
24 auth.
S. Ogawa,
T. Yamashita,
T. Yamazaki,
Y. Aizawa,
H. Atarashi,
H. Inoue,
T. Ohe,
H. Ohtsu,
K. Okumura,
T. Katoh,
...
S. Kamakura,
K. Kumagai,
Y. Kurachi,
I. Kodama,
Y. Koretsune,
T. Saikawa,
M. Sakurai,
K. Sugi,
T. Tabuchi,
H. Nakaya,
T. Nakayama,
M. Hirai,
M. Fukatani,
H. Mitamura
|
7 |
2009 |
7 π
|
π’
|
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
13 auth.
K. Okumura,
M. Akao,
Tetsuro Yoshida,
M. Kawata,
O. Okazaki,
Shintaro Akashi,
K. Eshima,
K. Tanizawa,
Masayuki Fukuzawa,
Takuya Hayashi,
...
M. Akishita,
G. Lip,
T. Yamashita
|
7 |
2020 |
7 π’
|
π¦
|
Recruitment of immune cells across atrial endocardium in human atrial fibrillation.
9 auth.
T. Yamashita,
A. Sekiguchi,
Y. Iwasaki,
T. Date,
K. Sagara,
H. Tanabe,
...
H. Suma,
H. Sawada,
T. Aizawa
|
7 |
2010 |
7 π¦
|
π¬
|
Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study.
Takeshi Kato,
T. Yamashita,
K. Sagara,
H. Iinuma,
L. Fu
|
7 |
2004 |
7 π¬
|
π
|
What are Arrhythmogenic Substrates in Diabetic Rat Atria?
9 auth.
Takeshi Kato,
T. Yamashita,
A. Sekiguchi,
K. Sagara,
M. Takamura,
S. Takata,
...
S. Kaneko,
T. Aizawa,
L. Fu
|
7 |
2006 |
7 π
|
π
|
AGEsβRAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat
9 auth.
Takeshi Kato,
T. Yamashita,
A. Sekiguchi,
Takayuki Tsuneda,
K. Sagara,
M. Takamura,
...
S. Kaneko,
T. Aizawa,
L. Fu
|
6 |
2008 |
6 π
|
π
|
Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
24 auth.
H. Inoue,
K. Okumura,
H. Atarashi,
T. Yamashita,
H. Origasa,
N. Kumagai,
M. Sakurai,
Y. Kawamura,
I. Kubota,
Kazuo Matsumoto,
...
Y. Kaneko,
S. Ogawa,
Y. Aizawa,
M. Chinushi,
I. Kodama,
E. Watanabe,
Y. Koretsune,
Y. Okuyama,
A. Shimizu,
O. Igawa,
S. Bando,
M. Fukatani,
T. Saikawa,
A. Chishaki
|
6 |
2013 |
6 π
|
π¦
|
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
25 auth.
T. Yamashita,
H. Inoue,
K. Okumura,
I. Kodama,
Y. Aizawa,
H. Atarashi,
T. Ohe,
H. Ohtsu,
Takao Kato,
S. Kamakura,
K. Kumagai,
Y. Kurachi,
Y. Koretsune,
T. Saikawa,
M. Sakurai,
...
Toshiaki Sato,
K. Sugi,
H. Nakaya,
M. Hirai,
A. Hirayama,
M. Fukatani,
H. Mitamura,
T. Yamazaki,
E. Watanabe,
S. Ogawa
|
6 |
2011 |
6 π¦
|